Autolus Therapeutics ($AUTL) Insider Trading & Smart Money Activity

Autolus Therapeutics plc · Biotechnology · Latest filing Aug 14, 2025

Autolus Therapeutics plc ($AUTL) has 2 13F position changes on file.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 0
Net insider $ (12 mo): $0
Congress trades (12 mo): 0
13F moves on file: 2
Analyst ratings on file: 0

AUTL insider buying and selling by quarter

Quarter	Congress buys / sales	13F added / cut
Q1 2026	0 / 0	0 / 0
Q2 2026	0 / 0	0 / 0
Q3 2026	0 / 0	0 / 0
Q4 2026	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All AUTL insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Aug 14, 2025	13F	Avoro Capital Advisors	Sold out	-9.91M sh							Read
Aug 14, 2025	13F	Avoro Capital Advisors	Sold out	-9.91M sh							Read

1W / 1M / 6M = how AUTL moved from the trade or filing date.

Institutions moving AUTL (13F)

Avoro Capital Advisors2

Frequently asked questions

Which institutions changed their AUTL positions?

Recent 13F filers moving the stock include Avoro Capital Advisors.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text